Used in pharmaceutical research as a key scaffold in the development of kinase inhibitors, particularly targeting PDE10A for potential treatment of neurological disorders such as schizophrenia and Huntington’s disease. Its structure enables selective binding to enzyme active sites, enhancing drug specificity. Also explored in medicinal chemistry for optimizing metabolic stability and bioavailability in central nervous system-targeted therapies.